Which company is the manufacturer of pemetinib/pemetinib?

Pemigatinib(Pemigatinib) is an oral targeted drug developed and produced by Incyte. It is mainly used for the treatment of cholangiocarcinoma (CCA). Incyte is a biopharmaceutical company headquartered in the United States, focusing on the research and development of innovative oncology drugs and immunomodulatory drugs. Pemetinib, as one of its core R&D products, has been verified through rigorous clinical trials and has shown clear efficacy in patients with advanced cholangiocarcinoma, and has been approved for marketing in many countries.

In China, pemetinib is supplied byIncyte authorized or in cooperation with local distribution channels. At the same time, some overseas generic drug manufacturers also provide corresponding products. For example, the generic version of pemetinib produced by Lucius Pharmaceuticals in Laos has basically the same ingredients as the original drug, but the price is significantly lower than the original drug. This overseas generic drug provides patients with an economically viable alternative, especially for patients with high long-term treatment needs.

Incyte has strict standards in drug production and quality control to ensure the purity, stability and consistency of efficacy of the original drugs. The production of pemetinib involves strict GMP certification, and each batch of drugs must undergo quality testing before being put on the market to ensure patient drug safety. At the same time, the company also provides related patient support services, including medication guidance and adverse reaction management, to help patients obtain a better quality of life during the treatment process.

In short, the manufacturer of the original drug Pemetinib is Incyte Company of the United States.The drug is marketed in many countries around the world. At the same time, some overseas generic drug manufacturers also provide products with similar ingredients, providing patients with diversified choices. Understanding the manufacturer and source of drugs can help patients ensure drug safety and efficacy when taking drugs.

Reference materials:https://go.drugbank.com/drugs/DB15102